Mariana Wolf has a degree in Biotechnology and has been part of the pharmaceutical industry since her first year at the University, where she had the opportunity to join the R&D team as intern at 3M Laboratory, participating in the development of Bronchodilators that at that time where manufactured for BI.
For some years, she was worked in the Clinical research area at IQVIA, ICON Plc, as a Regulatory Specialist in Clinical Studies of different therapeutic areas for South America.
She joined BI 8 years ago, to be part of the Clinical Operations Team as Regulatory Specialist for ROPU and then took on the challenge of leading that same team. Later, she took on the role of LATAM Clinical Studies Manager, where she had the opportunity to conduct studies in different therapeutic areas such as respiratory, cardiovascular, among others.
In 2020, Angels Argentina, Uruguay and Paraguay joined the team. Mariana is grateful for being part of the Initiative and motivated by its main objective.
Mariana is convinced that as a team, we can continue to contribute improving the quality of stroke care, so that more patients and their families have a second chance at life.